Bolt Biotherapeutics
Bolt Biotherapeutics is developing its novel BoltbodyTM platform, a cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).
Also Known As
Bolt Therapeutics
B2X
Board of Directors
CIK Number
Legal Name
BOLT BIOTHERAPEUTICS, INC.
Company Operating Status
Active
Competitors
Country
Crunchbase URL
Date Incorporated
2015
Email Address
info@boltbio.com
Founded Date
2015
Founder
Full Address
900 Chesapeake Drive Redwood City, CA 94063, USA
IRS Number
472,804,636
0
Latest Funding Round Date
July 1, 2020
Latest Funding Round Amount (USD)
93,500,000
Latest Funding Type
LinkedIn URL
Number of Employees
87
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
1
Phone Number
+13109093218
+16506659295
Pitchbook URL
Place of Incorporation
Previous Name
Bolt Therapeutics, Inc.
0
SIC Code
2,834
0
Exchange
Stock Symbol
BOLT
0
Ticker Symbol
BOLT
Total Funding Amount (USD)
147,500,000
Twitter URL
Official Website
Find more companies like Bolt Biotherapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.